Magnesium: glycinate, citrate or oxide, and why the form matters
Only one human trial here compared magnesium forms side by side. Citrate and an amino-acid chelate were absorbed better than oxide, which did no better than a dummy capsule. Glycinate was not in it.

Citrate came out ahead in the one human trial here that compared forms. Forty-six people took 300 mg a day of magnesium as citrate, as an amino-acid chelate, as oxide, or took a dummy capsule, for 60 days.1 Citrate and the chelate were absorbed better than oxide. Oxide came out no different from the dummy.1 Glycinate was not tested.
The trial that compared them
The comparison exists, it is small, and it is old.
Forty-six healthy people were assigned to one of three magnesium preparations, or to a dummy, all at 300 mg of elemental magnesium a day for 60 days.1 Urine, blood and saliva were sampled at the start, 24 hours after the first dose, and at the end.1
The two organic forms, citrate and the amino-acid chelate, were absorbed better than oxide by the end, judged by how much magnesium turned up in a day's urine.1 Citrate produced the highest blood magnesium of any treatment, both after one dose and after two months.1 Oxide produced no differences from the dummy capsule at all.1
Four groups and 46 people works out to about a dozen per group.1 That is thin. It is also the best direct evidence there is on the question the supplement aisle is organized around.
What "better absorbed" was measured with
The endpoints are worth separating, because they are not equivalent. Urine tells you how much magnesium got into the body and back out again. Blood tells you how much was circulating. Saliva is a convenience measure.
Red cell magnesium is the closest thing here to a tissue store, and it showed no differences between the groups.1 So the form changed the numbers that turn over quickly and left the slow one alone, across 60 days.1 Whether that matters depends on which number predicts an outcome, and this trial was not built to find out.
There is a further wrinkle in reading absorption off urine. Magnesium in urine is magnesium the kidney is throwing away. The same reading can mean good uptake, or a body with no room for more. Reporting it as absorption is the convention, and a convention is not a measurement of what reached the tissues.
The glycinate gap
Glycinate is the form most recommended online, and it does not appear in any of these abstracts: not the comparison trial, not the blood pressure reviews, not the animal work.
The nearest relative is the amino-acid chelate arm, though the abstract does not say which amino acid was used, so it cannot stand in for glycinate. That arm beat oxide on urinary excretion, and did not beat citrate on blood magnesium.1
So an amino-acid chelate outperformed oxide on one marker. It is not fair to say a trial has shown glycinate beats citrate. No trial here tried.
The confident three-way ranking that circulates online has no comparative trial behind it in this evidence.
The widest comparison anyone ran was in rats
One study ranked many salts at once. It used 80 magnesium-depleted rats and a labeled tracer, feeding ten different salts including oxide, citrate, gluconate, lactate and aspartate.2 Absorption ranged from 50% to 67%, organic salts came out slightly ahead of inorganic ones, and gluconate ranked highest.2
Urinary excretion of the labeled magnesium ran from 0.20 mg to 0.33 mg, and retention was higher on gluconate, lactate and aspartate than on the inorganic salts.2
Two things follow. In the study most likely to find a difference, the whole spread across every salt tested was 17 percentage points of absorption.2 And these were rats, depleted for three weeks first, which is a design built to widen differences rather than to reproduce a person taking a capsule with dinner.
Its top salt, gluconate, is not one of the three forms this post is about.
Where absorption stops mattering
Blood pressure is a common outcome in magnesium trials, and here the form question quietly disappears. The abstracts of the large analyses do not report which salt the trials used.
The most recent gathered 38 trials and 2709 participants, at doses from 82.3 mg to 637 mg, median 365 mg, over a median of 12 weeks.3 Systolic pressure fell by 2.81 mm Hg and diastolic by 2.05.3 In people with high blood pressure already on medication the systolic drop was 7.68, and in people low on magnesium it was 5.97.3 In people whose pressure was normal it did not reach significance.3
Then comes the finding that matters most here. There was no relationship between dose and effect at all, with every p value at or above 0.20.3 If dose does not predict the outcome, a form that delivers somewhat more magnesium may not either.
The dose findings across reviews also contradict one another. A review of ten reviews and 8610 participants found the largest reductions at 400 mg a day or more, at 6.38 mm Hg systolic.4 A review restricted to people with normal blood pressure found the opposite: 360 mg a day or less gave 3.03 mm Hg, and courses beyond 3 months gave 4.31.5 An earlier analysis of 34 trials and 2028 participants landed at 2.00 mm Hg systolic and 1.78 diastolic, at a median 368 mg a day.6
That last one answers a question the others skip. 300 mg a day, or one month of it, was enough to raise blood magnesium, by 0.05 mmol/L over a dummy capsule.6 So the dose people actually take does arrive. Those trials did not sort by salt, so they cannot say which forms did the work.
Read together, the honest summary is a small blood pressure effect concentrated in people who are hypertensive or short of magnesium, on doses that do not line up from one review to the next.
What is still unknown
Whether glycinate does anything citrate does not. No trial in this set includes it.
Whether the laxative difference is real in trial data. It is the most common reason people switch forms, and none of these abstracts reports stool outcomes or side effects by salt.
Whether the absorption markers predict anything at all. The one trial that measured several found form effects on urine, blood and saliva, and none on red cell magnesium.1
And which salts the outcome trials used. Every blood pressure analysis here sorts by dose and duration, not by form, which means the question this post is about has never been put to an outcome.3
QUESTIONS THIS POST ANSWERS
- Why does magnesium oxide cause loose stools?
- This evidence set does not answer it. None of these trials reported stool frequency, diarrhea or adverse events broken down by magnesium form, so the effect everyone knows about is undocumented here. What the record does show is that oxide produced no differences from placebo across 60 days, and nothing here says why.
- Is magnesium from food absorbed better than from supplements?
- No study here compares food with a supplement, so the comparison cannot be made from this evidence. What the supplement trials establish is that the doses people actually take do reach the blood: a median of 368 mg a day for three months raised serum magnesium by 0.05 mmol/L against placebo. Those reviews did not sort trials by salt, so they cannot say whether the form changed how much arrived.
REFERENCES
Each reference was re-checked against PubMed before publication. How sources are checked
- 1Walker AF, et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnesium research. 2003. Source
- 2Coudray C, et al. Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnesium research. 2005. Source
- 3Argeros Z, et al. Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hypertension (Dallas, Tex. : 1979). 2025. Source
- 4Alharran AM, et al. Impact of Magnesium Supplementation on Blood Pressure: An Umbrella Meta-Analysis of Randomized Controlled Trials. Current therapeutic research, clinical and experimental. 2024. Source
- 5Behers BJ, et al. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients. 2024. Source
- 6Zhang X, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension (Dallas, Tex. : 1979). 2016. Source